Patent References 2846445 2846446 2897202 3644425 N-substituted-17ଲ-carbamoylandrost-4-en-3-one 5 reductase inhibitors Novel steroid 5-reductase inhibitors D-Homosteroids 4-Aza-17ଲ-substituted-5-androstan-3-one-reductase inhibitors Steroidic 5-reductase inhibitors 17ଲ-N-monosubstituted carbamoyl-4-aza-5-androst-1-en-3-ones which are active as testosterone 5-reductase inhibitors Patent #: 4760071 InventorsAssigneeApplicationNo. 419563 filed on 10/10/1989US Classes:548/250, Tetrazoles (including hydrogenated)514/284, Tetracyclo ring system having the six-membered hetero ring as one of the cyclos549/331, The spiro includes a hetero ring558/429, The ring system contains at least three cyclos560/117Tricyclo ring system in acid moietyExaminersPrimary: Shah, Mukund J.Assistant: Ward, E. C. Attorney, Agent or FirmInternational ClassesC07D 307/94C07D 257/04 C07C 069/608 AbstractInvented are 4-aza-5-alpha-8(14)-17 substituted-androsten-3-ones having an 8(14), 7(8), or 16(17) double bond, optionally also having a 1(2) double bond, pharmaceutical compositions containing the compounds, and methods of using these compounds to inhibit steroid 5-alpha-reductase.Other References
Field of SearchThe spiro includes a hetero ringTetrazoles (including hydrogenated) Polycyclo carbocyclic ring system having at least three cyclos 1,3-oxazoles (including hydrogenated) The polycyclo ring system is tricyclo-carbocyclic The six-membered hetero ring shares ring members with one other cyclo only Oxygen attched directly or indirectly to morpholine ring by nonionic bonding Polycyclo-carbocyclic ring system having at least three cyclos The ring system contains at least three cyclos Tricyclo ring system in acid moiety |
| ||||||||||||||